EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gastric Microbiota Dysbiosis and Microbiome-Based Interventions in Chronic Atrophic Gastritis

Ang Li iD, Yang He, Bushra Walayat, Aamir Saleem iD, Jing Zhao, Qian Wang, Xiulin Zhang, Changlong Li, Yinhui Liu iD, Shuming Lu, Ming Li iD

Nutrients · 2026

DOI: 10.3390/nu18132165 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Ang Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Science, Dalian Medical University, Dalian 116044, China. Hauptthemen laut MEDLINE: Gastritis, Atrophic, Dysbiosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dalian Science and Technology Innovation Project, Liaoning Provincial Department of Education Basic Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic atrophic gastritis (CAG) is a pivotal precancerous condition in gastric carcinogenesis, with progression typically following the classic Correa cascade. Although Helicobacter pylori (H. pylori) infection is widely recognized as the principal etiological factor, the persistence of gastric cancer (GC) risk in a subset of patients after successful eradication suggests that gastric microbiota dysbiosis may also contribute to CAG progression. In recent years, high-throughput sequencing technologies have revealed distinct microbial restructuring in patients with CAG, characterized by decreased microbial diversity, depletion of commensal taxa, and enrichment of opportunistic pathogens. These compositional changes are accompanied by metabolic dysfunction, activation of inflammatory signaling pathways, and disruption of immune homeostasis, which may contribute to a microenvironment permissive for precancerous transformation of the gastric mucosa. Probiotics and related microbiome-based therapeutics, including prebiotics, synbiotics, and postbiotics, have emerged as promising adjunctive strategies for H. pylori eradication and disease management. Their beneficial effects are mediated through multiple mechanisms, including remodeling of the microbial community, inhibition of pathogen colonization, modulation of host immune responses, and restoration of mucosal barrier integrity. However, whether these interventions can reverse established atrophic or metaplastic lesions remains unclear. In addition, how strain specificity, dose dependency, and interindividual heterogeneity influence clinical efficacy has yet to be fully elucidated. In this review, we summarize the compositional and functional features of gastric microbiota dysbiosis in patients with CAG, as well as the mechanisms and clinical applications of microbiome-based interventions. We further highlight current limitations in the field and discuss future directions for precision microecological therapies integrating multi-omics approaches, engineered probiotics, and artificial intelligence. These advances may provide a theoretical framework and practical guidance for the diagnosis and management of CAG and the prevention of GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastritis, AtrophicDysbiosisGastrointestinal MicrobiomeHumansProbioticsHelicobacter pyloriHelicobacter InfectionsStomach NeoplasmsGastric MucosaChronic DiseaseAnimals

Stichwörter der Autor:innen

CAGCorrea cascadeH. pylori infectionchronic atrophic gastritisgastric microbiota/gastric microbiomemicrobial dysbiosisprobiotics

Autor:innen und Institutionen

  • College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
  • CapitalBio Technology (Liaoning) Co., Ltd., Dalian 116016, China.
  • School of Nursing, Dalian Medical University, Dalian 116044, China.
  • Beijing Key Laboratory of Cancer Invasion and Metastasis Research, Department of Medical Genetics and Developmental Biology, School of Basic Medical Science, Capital Medical University, Beijing 100069, China.
  • Department of Gastroenterology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.

ORCID-Profile: Ang Li, Aamir Saleem, Yinhui Liu, Ming Li

Förderung

  • Dalian Science and Technology Innovation Project
  • Liaoning Provincial Department of Education Basic Scientific Research Project

Zitieren

APA

Li, A., He, Y., Walayat, B., Saleem, A., Zhao, J., Wang, Q., Zhang, X., Li, C., Liu, Y., Lu, S., & Li, M. (2026). Gastric Microbiota Dysbiosis and Microbiome-Based Interventions in Chronic Atrophic Gastritis. Nutrients. https://doi.org/10.3390/nu18132165

Vancouver

Li A, He Y, Walayat B, Saleem A, Zhao J, Wang Q, et al. Gastric Microbiota Dysbiosis and Microbiome-Based Interventions in Chronic Atrophic Gastritis. Nutrients. 2026. doi:10.3390/nu18132165

BibTeX
@article{Li2026,
  author = {Li, Ang and He, Yang and Walayat, Bushra and Saleem, Aamir and Zhao, Jing and Wang, Qian and Zhang, Xiulin and Li, Changlong and Liu, Yinhui and Lu, Shuming and Li, Ming},
  title = {Gastric Microbiota Dysbiosis and Microbiome-Based Interventions in Chronic Atrophic Gastritis},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18132165}
}
Kostenlos starten →